Cargando…
Cyclotherapy: opening a therapeutic window in cancer treatment
Cyclotherapy is a promising endeavor to improve cancer treatment by tackling the dose-limiting side effects of chemotherapy, especially for cancers harboring mutations in the TP53 tumor suppressor. In this particular context, pre-treatment with a p53 activator halts proliferation in healthy tissue,...
Autor principal: | van Leeuwen, Ingeborg M.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442291/ https://www.ncbi.nlm.nih.gov/pubmed/22711025 |
Ejemplares similares
-
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
por: Rao, Bhavya, et al.
Publicado: (2010) -
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy
por: Jackson, Robert C., et al.
Publicado: (2017) -
p53-Based cyclotherapy: exploiting the ‘guardian of the genome' to protect normal cells from cytotoxic therapy
por: Rao, B, et al.
Publicado: (2013) -
Disease and “Broken Windows”
por: Meléndez, Leo
Publicado: (2005) -
“Broken Windows”: Frumkin Responds
por: Frumkin, Howard
Publicado: (2005)